Bictegravir Sodium, Emtricitabine, / Tenofovir Alafenamide Fumarate

Common brands: Biktarvy, Truvada, Viread, Genvoya, Stribild

Top reporter: Gilead Sciences, Inc.

Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Cytochrome P450 3A Inhibitor [EPC]Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]Protease Inhibitor [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]
17,624
Total Reports
11,937
Serious Reports
692
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (3.93%)

Patient Demographics

Male
12,150
Female
4,321

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Bictegravir Sodium, Emtricitabine, / Tenofovir Alafenamide Fumarate.

# Reaction Reports % of Total
1 BONE DENSITY DECREASED 6,570
12.4%
2 CHRONIC KIDNEY DISEASE 3,619
6.8%
3 BONE LOSS 3,448
6.5%
4 TOOTH LOSS 3,396
6.4%
5 OSTEONECROSIS 3,370
6.4%
6 MULTIPLE FRACTURES 3,134
5.9%
7 RENAL FAILURE 3,002
5.7%
8 OSTEOPOROSIS 2,766
5.2%
9 PAIN 2,542
4.8%
10 RENAL INJURY 2,486
4.7%
11 EMOTIONAL DISTRESS 2,435
4.6%
12 ANXIETY 2,277
4.3%
13 ANHEDONIA 2,154
4.1%
14 SKELETAL INJURY 2,120
4.0%
15 OSTEOPENIA 1,867
3.5%
16 ACUTE KIDNEY INJURY 811
1.5%
17 RENAL IMPAIRMENT 807
1.5%
18 BLOOD CREATININE INCREASED 784
1.5%
19 ECONOMIC PROBLEM 695
1.3%
20 TOOTH INJURY 503
0.9%
21 VITAMIN D DEFICIENCY 478
0.9%
22 WEIGHT INCREASED 477
0.9%
23 BONE DENSITY ABNORMAL 467
0.9%
24 DEATH 457
0.9%
25 FRACTURE 456
0.9%
26 DEPRESSION 403
0.8%
27 FATIGUE 398
0.8%
28 NEPHROPATHY 357
0.7%
29 FOOT FRACTURE 344
0.6%
30 NAUSEA 325
0.6%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.